Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06418282 · ClinicalTrials.gov registry record · NA
Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema
A NA study of Lymphedema and Chronic Venous Insufficiency, sponsored by Koya Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06418282: Recruiting NA study of Lymphedema and Chronic Venous Insufficiency, sponsored by Koya Medical.
NCT06418282 is a NA study of Lymphedema and Chronic Venous Insufficiency that is actively recruiting participants, run by Koya Medical. The registered enrollment target is 100 participants, below the 9,297-participant average among 34 other Lymphedema trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06418282, a NA study of Lymphedema and Chronic Venous Insufficiency, is actively recruiting participants, sponsored by Koya Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
An open-label, multi-center, prospective VA study to evaluate the effectiveness and health economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for lymphedema/phlebolymphedema
Primary Outcome
Cost comparison between NPCD and historical reference (as reflected by hospital/resource utilization related to adverse events)
Conditions Studied
Interventions
- DEVICE Dayspring
Study Locations (1)
New York
- Glenn Jacobowitz - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-05-13 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
What NCT06418282 shows while recruiting
NCT06418282 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 9,297-participant average among 34 other Lymphedema trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Lymphedema appearing as the primary indexed condition, and to 1 intervention - of which Dayspring is the first listed.
NCT06418282 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06418282 about?
NCT06418282 is a clinical study titled "Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema". An open-label, multi-center, prospective VA study to evaluate the effectiveness and health economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for lymphedema/phlebolymphedema
What is the current status of trial NCT06418282?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-05-13. Estimated completion is 2026-01-31.
What conditions does trial NCT06418282 study?
This clinical trial studies the following conditions: Lymphedema, Chronic Venous Insufficiency, Phlebolymphedema.
What interventions are being tested in trial NCT06418282?
The interventions under investigation include: Dayspring (DEVICE).
Who is sponsoring clinical trial NCT06418282?
This trial is sponsored by Koya Medical, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06418282 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphedema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06418282's enrollment target sits among peer trials
100 19th of 34 higher than 16 of 34 other Lymphedema trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lymphedema trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
RECRUITING · NA
-
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery
RECRUITING · NA
-
Pedal Pump and Leg Lymphedema
RECRUITING · NA
-
Comparing Two Ways to Manage Head and Neck Lymphedema
RECRUITING · NA
-
LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
RECRUITING · NA
-
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI